MBX Ora H Pescovitz buys $45K worth of shares
Apr 11, 2025, 4:38 AM
0.00%
What does MBX do
MBX Biosciences, a clinical-stage biopharmaceutical company based in Carmel, Indiana, focuses on precision peptide therapies for endocrine and metabolic disorders and went public on September 13, 2024. Its product candidates include MBX 2109, MBX 1416, and MBX 4291, targeting various hormone-related conditions.
Ora H Pescovitz bought 7,693 shares of MBX on 8 April at $5.89 per share, worth a total of $45K. They now own 24,329 MBX shares, or a 46% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.